Gastrointestinal stromal tumour (GIST): British Sarcoma Group clinical practice guidelines.
Loading...
Embargo End Date
ICR Authors
Authors
Judson, I
Jones, RL
Wong, NACS
Dileo, P
Bulusu, R
Smith, M
Almond, M
Jones, RL
Wong, NACS
Dileo, P
Bulusu, R
Smith, M
Almond, M
Document Type
Journal Article
Date
2025-01-31
Date Accepted
2024-03-25
Abstract
BACKGROUND: British Sarcoma Group guidelines for the management of GIST were initially informed by those published by the European Society of Clinical Oncology. This update was written by a group of experts to includes a discussion of the highlight improvements in our knowledge of the disease and recent treatment developments. The guidelines include sections on Incidence, Aetiology, Diagnosis, including risk assessment, Treatment and Follow-up. METHODS: A careful review of the literature was performed to ensure that wherever possible recommendations are supported by the results of clinical trials or substantive retrospective reports. Areas of uncertainty are indicated appropriately. CONCLUSION: Guidelines represent a consensus view of current best clinical practice. Where appropriate, key recommendations are given and the levels of evidence and strength of recommendation gradings are those used by the European Society for Medical Oncology (ESMO).
Citation
British Journal of Cancer, 2024,
Source Title
British Journal of Cancer
Publisher
SPRINGERNATURE
ISSN
0007-0920
eISSN
1532-1827
1532-1827
1532-1827
Collections
Research Team
Sarcoma Clinical Trials
Translational Sarcoma, Melanoma and Rare Tumour Surgery
Translational Sarcoma, Melanoma and Rare Tumour Surgery